Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHIANTI: Colchicine in Aortic Valve Stenosis
NCT05162742Phase 3Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2022
- Primary completion
- Dec 2026
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in aortic valve stenosis comparing Colchicine with Placebo (2 arms). Primary endpoint: Change in aortic valve calcium score at 24 months. Started Dec 2022; status: active, not recruiting.
02
Drugs
colchicine
03
Conditions
aortic valve stenosis
Beyond the preview
Go deeper on NCT05162742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05162742.